Independent Advisor Alliance Catalent, Inc. Transaction History

Independent Advisor Alliance

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$45.44 - $74.26 $320,306 - $523,458	7,049 New	7,049 $463,000
Q3 2022 Nov 04, 2022	SELL	$72.36 - $113.1 $10,926 - $17,078	-151 Reduced 1.43%	10,421 $754,000
Q2 2022 Aug 04, 2022	BUY	$87.2 - $114.05 $56,331 - $73,676	646 Added 6.51%	10,572 $1.13 Million
Q1 2022 May 06, 2022	BUY	$94.19 - $124.49 $934,929 - $1.24 Million	9,926 New	9,926 $1.1 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

Stay updated on Independent Advisor Alliance with notifications on news.